MedTrace Logo

Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE

NCT01021514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2011-04-06

No results posted yet for this study

Summary

Arteriosclerosis is a dynamic inflammatory disorder. Recently, FDG-PET CT is emerging diagnostic tool of non-invasive technique to detect vulnerable atherosclerotic plaque. And there are arising evidence that sRAGE(soluble Receptor for Advanced glycation End Product) is correlated with metabolic risk. So the investigators will investigate association between sRAGE and FDG-PET uptake in large artery in healthy patient.

Conditions

  • sRAGE Level
  • SUV and TBR Levels in FDG PET

Sponsors & Collaborators

  • Korea University

    lead OTHER

Principal Investigators

  • Kyoungmook Choi, MD, PhD · Korea University Guro Hospital

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-08-31
Completion
2010-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01021514 on ClinicalTrials.gov